Minireviews
Copyright ©The Author(s) 2019.
World J Gastrointest Endosc. Feb 16, 2019; 11(2): 103-114
Published online Feb 16, 2019. doi: 10.4253/wjge.v11.i2.103
Table 2 Studies comparing endoscopic ultrasound-guided biliary drainage and percutaneous transhepatic cholangiography
Author, YrType of studyType malignant obstructionNumber patientsTechnical Succes rateClinical Succes rateComplications, EUS vs PTC
Téllez-Ávila et al[60], 2018(1) Retrospective; and (2) Failed ERCP(1) Malignant 56.4%; and (2) Distal(1) Total: 62; (2) EUS: 30; and (3) PTC: 32(1) EUS: 90%; and (2) PTC: 78.1%(1) EUS: 96%; and (2) PTC: 63%Overall: 6% vs 28.1%
Sportes et al[57], 2017(1) Retrospective, multicenter; and (2) Failed ERCP or altered anatomy(1) Unresectable; and (2) Distal(1) Total: 51; (2) EUS: 31; and (3) PTC: 20(1) EUS: 100%; and (2) PTC: 100%(1) EUS: 86%; and (2) PTC: 83%(1) Overall: 16% vs 10%; and (2) Reintervention: 6.5% vs 105%
Lee et al[58], 2016(1) Randomized, multicenter; and (2) Inaccessible papilla(1) Unresectable; and (2) Distal(1) Total: 66; (2) EUS: 34; and (3) PTC: 32(1) EUS: 94.1%; and (2) PTC: 96.9%(1) EUS: 87.5%; and (2) PTC: 87.1%(1) Overall: 8.8% vs 31.2%; and (2) Reintervention: 25% vs 54.8%
Torres-Ruiz, 2016; AbstractFailed ERCPDistal and proximal(1) Total: 66; (2) EUS: 35; and (3) PTC: 31(1) EUS: 81%; and (2) PTC: 90.3%(1) EUS: 90%; and (2) PTC: 68.7%(1) Early: 10.8% vs 9%; (2) Late: 16.6% vs 54%; and (3) Reintervention: 8.5% vs 45.1%
Sharaiha et al[56], 2016(1) Retrospective, single center; and (2) Failed ERCPMalignant: 83.3%(1) Total: 60; (2) EUS: 47; and (3) PTC: 13(1) EUS: 93.3%; and (2) PTC: 91.6%(1) EUS: 62.2%; and (2) PTC: 25%(1) Late: 6.6% vs 53.8%; and (2) Reintervention: 6.6% vs 53.8%
Bill et al[59], 2015(1) Retrospective, single center; and (2) Failed ERCPDistal(1) Total: 50; (2) EUS: 25; and (3) PTC: 25(1) EUS: 76%; and (2) PTC: 100%(1) EUS: 96%; and (2) PTC: 80%(1) Early: 16% vs 12%; (2) Late: 12% vs 5%; and (3) Reintervention: 15.8% vs 60%
Giovannini, 2015; Abstract(1) Randomized, multicenter; and (2) Failed ERCP or impossibleMalignant: 90.2%(1) Total: 41; (2) EUS: 20; and (3) PTC: 21(1) EUS: 95%; and (2) PTC: 100%(1) EUS: 95%; and (2) PTC: 85%Overall: 35% vs 60%
Khashab et al[45], 2015(1) Retrospective, multicenter; and (2) Failed ERCPDistal(1) Total: 73; (2) EUS: 22; and (3) PTC: 51(1) EUS: 86.4%; and (2) PTC: 100%(1) EUS: 86.4%; and (2) PTC: 92.2%(1) Overall: 18.2% vs 39.2%; and (2) Reintervention: 15.7% vs 80.4%
Bapaye et al[55], 2013(1) Retrospective, single center; and (2) Inaccessible papilUnresectable(1) Total: 51; (2) EUS: 25; and (3) PTC: 26(1) EUS: 92%; and (2) PTC: 46%(1) EUS: 92%; and (2) PTC: 46%Overall: 20% vs 46%
Artifon et al[54], 2012(1) Prospective, randomized; and (2) Failed ERCPUnresectable(1) Total: 25; (2) EUS: 13; and (3) PTC: 12(1) CDS: 100%; and (2) PTC: 100%(1) CDS: 100%; and (2) PTC: 100%Overall: 15.3% vs 25%